Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Shares Outstanding (2016 - 2025)

OptimizeRx (OPRX) has disclosed Shares Outstanding for 16 consecutive years, with $20.5 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 11.1% to $20.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.5 million through Dec 2025, up 11.1% year-over-year, with the annual reading at $20.5 million for FY2025, 1.52% up from the prior year.
  • Shares Outstanding hit $20.5 million in Q4 2025 for OptimizeRx, up from $18.6 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $20.5 million in Q4 2025 to a low of -$1.7 million in Q3 2023.
  • Historically, Shares Outstanding has averaged $15.9 million across 5 years, with a median of $18.3 million in 2022.
  • Biggest five-year swings in Shares Outstanding: surged 154898.1% in 2021 and later plummeted 109.48% in 2024.
  • Year by year, Shares Outstanding stood at $17.9 million in 2021, then increased by 2.39% to $18.3 million in 2022, then grew by 8.81% to $19.9 million in 2023, then dropped by 7.27% to $18.5 million in 2024, then grew by 11.1% to $20.5 million in 2025.
  • Business Quant data shows Shares Outstanding for OPRX at $20.5 million in Q4 2025, $20.3 million in Q3 2025, and $20.3 million in Q2 2025.